Carbohydrate exchange changes at the different types of antihypertensive therapy in patients with hypertension and obesity

Abstract

Growing prevalence of the combined course of hypertension and obesity which lead to a summation of cardiovascular risk, causes search of new therapeutic strategies. There are differences between antihypertenzive drugs both in one class, and between different classes, which concern all range the pharmacodynamic of effects.